MORE►
Sulagna Bhattacharya
Glenn Sblendorio, chairman of the board of Nanoscope Therapeutics [Photo: Nanoscope Therapeutics, eye: Faysal Ahamed/istock; ]
Nanoscope Therapeutics Names Finance and Biotech Leader as Board Chairman
by Lance Murray | Dec 8, 2023
Splendorio's more than 30 years of experience have been marked by extensive executive leadership in the ophthalmic industry, and he will support Nanoscope in reaching its strategic vision, the company said.
by Lance Murray |
Oct 27, 2023
Najam Sharif, Ph.D., DSc, has been appointed as vice president of global research and development by Dallas-based Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.
Sharif is a veteran in drug/device discovery and development, the company said.
“We are delighted to welcome Naj to the Nanoscope team,” Sulagna Bhattacharya, co-founder and CEO of Nanoscope, said in a statement....
MORE►
by Lance Murray |
Sep 22, 2023
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
MORE►
by Dallas Innovates | Staff Report |
Apr 4, 2023
Dr. Zajicek and three other local biotech leaders—Sulagna Bhattacharya, CEO of Nanoscope Therapeutics; Gabby Everett, director of business operations and strategy at BioLabs Pegasus Park; and R.A. Session II, founder of Taysha Gene Therapies—discussed Dallas' biotech boom on a panel hosted by D CEO Healthcare.
MORE►
The Future 50 in Dallas-Fort Worth 2023: Meet the Game-Changing Disruptors Driving Innovation and Impact
by Quincy Preston | Mar 16, 2023
These standouts—startup founders, tech pioneers, educators, creators, social innovators, and business leaders—are transforming entire industries and making waves in their respective fields.
MORE►
by Quincy Preston |
Mar 16, 2023
Meet the startup innovators who are driving change in their industries and beyond. These startups are among the Future 50 in Dallas-Fort Worth, our editors’ picks of forward-thinking innovators who are shaping their industries and communities.
From the healthcare sector to the real estate industry, these trailblazers are disrupting the status quo with their groundbreaking technologies and solutions....
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 11, 2023
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
MORE►
Meet the 11 Winners of the EY Entrepreneur Of The Year 2022 Central Plains Award
by Kevin Cummings | Jun 27, 2022
Ten of the 11 winners are from North Texas.
MORE►
by Dallas Innovates | Staff Report |
Feb 18, 2022
In this week's roundup of hires, promotions, and accolades in North Texas, you'll also find news from VERTESS, Mr. Cooper, Active Cyber, EarthX, SWK Holdings, and more.
Plus, Fort Worth Mayor Mattie Parker makes an appointment to the city council's Entrepreneurship and Innovation Committee.
Plus, Fort Worth Mayor Mattie Parker makes an appointment to the city council's Entrepreneurship and Innovation Committee.
MORE►
by David Seeley |
Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
